Learning Objectives
- An in-depth discussion of the most influential oncology trials presented in 2025 across various disease sites, highlighting key findings and their implications for clinical practice.
- A comprehensive review of the up-to-date standard treatment protocols for major hematological malignancies, ensuring that attendees are informed about the best practices and therapeutic options available.
- Discussion of the current controversies in the management of specific hematological cancers.
Chair
Dr. Martina Trinkaus
Dr. Matthew Seftel
Videos
Podcasts
This program has been made possible through unrestricted support from GSK, Lilly, and Merck
